Paper9303497
Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.
Maria VA and 1 other. Hepatology, 1997. Cited by 332 papers, by iCite.
Cite this record
ConductScience Library. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Papers, record 9303497. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9303497
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemical and Drug Induced Liver Injury | Major topic |
| Bias | |
| Diagnosis, Differential | |
| Humans | |
| Probability | |
| Random Allocation | |
| Reproducibility of Results |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02734966 | Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver Injury | Background |
Source ClinicalTrials.gov
Cited by137
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 332 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42652919 | Drug-Associated Vanishing Bile Duct Syndrome: Screening for Potential Pharmaceutical Triggers Using the WHO Pharmacovigilance Database. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42652919 | PubMed |
| 40636908 | Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled study. | ILIVER | 2023 | https://conductscience.org/library/papers/40636908 | PubMed |
| 40488658 | Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury. | Expert Opin Drug Metab Toxicol | 2025 | https://conductscience.org/library/papers/40488658 | PubMed |
| 40303582 | Drug-induced liver injury. Part I: Classification, diagnosis and treatment. | Clin Exp Hepatol | 2025 | https://conductscience.org/library/papers/40303582 | PubMed |
| 40166860 | Infliximab-induced autoimmune-like hepatitis in a patient with Crohn's disease: a case report. | Future Sci OA | 2025 | https://conductscience.org/library/papers/40166860 | PubMed |
| 39354283 | Investigation of the Role of Chemical Analysis in Causality Assessment of Herbal and Dietary Supplement-Induced Liver Injury. | Drug Saf | 2025 | https://conductscience.org/library/papers/39354283 | PubMed |
| 39166347 | Methods for causality assessment of idiosyncratic drug-induced liver injury. | Liver Int | 2025 | https://conductscience.org/library/papers/39166347 | PubMed |
| 38912001 | A comprehensive update in herbal and dietary supplement-induced liver injury. | Clin Liver Dis (Hoboken) | 2024 | https://conductscience.org/library/papers/38912001 | PubMed |
| 38198063 | Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry. | Drugs | 2024 | https://conductscience.org/library/papers/38198063 | PubMed |
| 37886185 | AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons. | Hepatobiliary Surg Nutr | 2023 | https://conductscience.org/library/papers/37886185 | PubMed |
| 37601069 | Advances in the study of acetaminophen-induced liver injury. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37601069 | PubMed |
| 37248984 | [Comparative analysis of clinical diagnosis and treatment guidelines for drug-induced liver injury at home and abroad]. | Zhonghua Gan Zang Bing Za Zhi | 2023 | https://conductscience.org/library/papers/37248984 | PubMed |
| 36174069 | A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT). | PLoS One | 2022 | https://conductscience.org/library/papers/36174069 | PubMed |
| 36066789 | The Dependence of Chance-Corrected Weighted Agreement Coefficients on the Power Parameter of the Weighting Scheme: Analysis and Measurement. | Psychometrika | 2023 | https://conductscience.org/library/papers/36066789 | PubMed |
| 35308476 | Drug-Induced Liver Injury: A Mexican View. | Clin Liver Dis (Hoboken) | 2022 | https://conductscience.org/library/papers/35308476 | PubMed |
| 34830594 | Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions. | J Clin Med | 2021 | https://conductscience.org/library/papers/34830594 | PubMed |
| 34502025 | High Risk of Viral Reactivation in Hepatitis B Patients with Systemic Lupus Erythematosus. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502025 | PubMed |
| 34383728 | Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury. | Am J Case Rep | 2021 | https://conductscience.org/library/papers/34383728 | PubMed |
| 34287244 | "Ain't She a Bute?": The Importance of Proper History Taking in a Case of Inappropriate Use of Horse NSAID in a Human. | Clin Pract | 2021 | https://conductscience.org/library/papers/34287244 | PubMed |
| 34274980 | Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes. | Arch Toxicol | 2021 | https://conductscience.org/library/papers/34274980 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9303497
GET https://conductscience.org/api/papers/v1/9303497/cited_by?page=2